luzindole has been researched along with galantamine in 1 studies
| Studies (luzindole) | Trials (luzindole) | Recent Studies (post-2010) (luzindole) | Studies (galantamine) | Trials (galantamine) | Recent Studies (post-2010) (galantamine) |
|---|---|---|---|---|---|
| 265 | 1 | 119 | 1,874 | 209 | 703 |
| Protein | Taxonomy | luzindole (IC50) | galantamine (IC50) |
|---|---|---|---|
| Chain A, ACETYLCHOLINESTERASE | Tetronarce californica (Pacific electric ray) | 0.652 | |
| Chain A, Acetylcholinesterase | Tetronarce californica (Pacific electric ray) | 0.36 | |
| Acetylcholinesterase | Electrophorus electricus (electric eel) | 2.0401 | |
| Acetylcholinesterase | Tetronarce californica (Pacific electric ray) | 0.488 | |
| Cholinesterase | Homo sapiens (human) | 5.4792 | |
| Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | 0.59 | |
| Acetylcholinesterase | Mus musculus (house mouse) | 2.29 | |
| Acetylcholinesterase | Homo sapiens (human) | 1.8484 | |
| Acetylcholinesterase | Bos taurus (cattle) | 4.53 | |
| Delta-type opioid receptor | Mus musculus (house mouse) | 8.3973 | |
| Vascular endothelial growth factor receptor 3 | Homo sapiens (human) | 0.59 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.59 | |
| Acetylcholinesterase | Rattus norvegicus (Norway rat) | 0.8006 | |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 3.2 | |
| Cholinesterase | Equus caballus (horse) | 7.2215 | |
| Carboxylic ester hydrolase | Equus caballus (horse) | 8.4178 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Egea, J; García, AG; López, MG; Romero, A | 1 |
1 other study(ies) available for luzindole and galantamine
| Article | Year |
|---|---|
Synergistic neuroprotective effect of combined low concentrations of galantamine and melatonin against oxidative stress in SH-SY5Y neuroblastoma cells.
Topics: Analysis of Variance; Cell Death; Cell Line, Tumor; Drug Synergism; Galantamine; Histocytochemistry; Humans; Mecamylamine; Melatonin; Neuroblastoma; Neuroprotective Agents; Oxidative Stress; Signal Transduction; Tryptamines | 2010 |